Strategic partnership with management to support Boulder Scientific’s next phase of growth
Iron Path Capital, a private equity firm focused on investing in companies within specialty chemicals & materials, engineered products & solutions and technical services that sell into highly regulated end markets, today announced the acquisition of Boulder Scientific Company ("Boulder Scientific" or the "Company") from Quad-C Management. The acquisition marks the first investment from Iron Path Capital Fund II, a $450 million partnership. Terms of the transaction were not disclosed.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261111797460/en/
Boulder Scientific is a leading manufacturer of high-performance organometallic compounds and a provider of complex synthetic chemistry capabilities with two facilities in Colorado. Since incorporated in 1961, the Company has grown to offer specialty chemicals to customers in the polyolefin, microelectronics, semiconductor, pharmaceutical, and aerospace and defense industries in the United States and around the world.
“Boulder Scientific is a differentiated, technically driven business that clearly aligns with our strategy of partnering with technical companies that have unique capabilities,” said Rob Reistetter, Managing Partner at Iron Path Capital. “We are excited to partner with the management team in the Company’s next phase of growth and look forward to supporting continued investment in its capabilities and expansion into existing and new end markets.”
Rich Preziotti, CEO of Boulder Scientific, commented: “The Boulder Scientific team is excited to partner with Iron Path Capital as we execute on our commitment to deliver outstanding science and support to existing and new customers in the target markets that we serve. We are highly optimistic that our growth plans in advanced catalysts, electronics, aerospace and defense, and life sciences will be enhanced through collaboration with Iron Path and the resources available to support Boulder’s continued growth.”
For more information visit bouldersci.com and ironpathcapital.com.
About Boulder Scientific Company:
Headquartered in Longmont, Colorado, Boulder Scientific is a manufacturer of organometallic compounds and specialty chemicals used in a range of applications and industries. Organometallics are mainly used as metallocene catalysts in polyolefin production, but Boulder Scientific’s products are also used in the pharmaceutical, electronics, industrials and aerospace & defense industries. Boulder Scientific also produces activators, ligands, air and moisture sensitive compounds, pyrophoric materials and other co-catalysts. Serving customers around the globe, Boulder Scientific operates two sites in Colorado. More information is available at https://www.bouldersci.com/.
About Iron Path Capital:
Iron Path Capital is an operationally focused private equity firm targeting specialized and technical lower middle market businesses, primarily within specialty chemicals & materials, engineered products & solutions and technical services, selling into highly regulated end markets. With offices in Nashville, TN, and Charlottesville, VA, Iron Path Capital supports its partners with capital, operating expertise, business development and industry relationships with the goal of achieving significant scale. Iron Path Capital leverages its extensive operating expertise to drive transformational growth at its portfolio companies. Learn more at ironpathcapital.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261111797460/en/
"Boulder Scientific is a differentiated, technically driven business that clearly aligns with our strategy of partnering with technical companies that have unique capabilities."
